Life Science Analytics (LSA)Overview Our Products
Each report also includes earnings and earnings per share, margin and return ratios, financial strength, growth ratios, day’s sales outstanding, day’s outstanding inventory, cash and short-term investments per share and total common shares outstanding. Finally each report includes quarterly book value per share vs. share price. Much of the information contained in each report is included in both tabular and graphic formats.
Product Pipeline Reports
Competitor Reports
Deals & Alliances Reports
|
List of reports from Life Science Analytics (LSA)
|
Argenta-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...
|
more...
|
$350.00
|
|
Cordex Pharma, Inc.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...
|
more...
|
$350.00
|
|
Caspian Tamin Pharmaceutical Company-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into ...
|
more...
|
$350.00
|
|
Fresenius Biotech GmbH-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...
|
more...
|
$350.00
|
|
Bio Products Laboratory Ltd. (BPL)-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... and competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight ...
|
more...
|
$350.00
|
|
Ram Pharmaceutical Industries Co. Ltd.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... and competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight ...
|
more...
|
$350.00
|
|
Lunan Pharmaceutical Group Corporation-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into ...
|
more...
|
$350.00
|
|
Immunocore Limited-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...
|
more...
|
$350.00
|
|
Laboratoires Plan SA-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...
|
more...
|
$350.00
|
|
University of Minnesota-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...
|
more...
|
$350.00
|
|
Newcastle University-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...
|
more...
|
$350.00
|
|
Neovacs SA-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...
|
more...
|
$350.00
|
|
Pharmex SA-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...
|
more...
|
$350.00
|
|
Tchaikapharma Inc-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...
|
more...
|
$350.00
|
|
University of Colorado Denver (UC Denver)-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... development, and competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as ...
|
more...
|
$350.00
|
|
BexPharm-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...
|
more...
|
$350.00
|
|
Astellas Pharma US, Inc.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into ...
|
more...
|
$350.00
|
|
Corridor Pharmaceuticals, Inc.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...
|
more...
|
$350.00
|
|
MCM Klosterfrau Vertriebs GmbH-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into ...
|
more...
|
$350.00
|
|
Amdipharm Plc-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...
|
more...
|
$350.00
|
|
Meridian Medical Technologies, Inc.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into ...
|
more...
|
$350.00
|
|
PriCara, division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... development, and competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as ...
|
more...
|
$350.00
|
|
Strativa Pharmaceuticals-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...
|
more...
|
$350.00
|
|
Sigma-Tau Pharmaceuticals, Inc.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...
|
more...
|
$350.00
|
|
sigma-tau SUDAN Ltd-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...
|
more...
|
$350.00
|

